Treating mouse models of astrocytomas with a new combination therapy resulted in tumor regression in 60% of the mice.
Treating mouse models of astrocytomas with a new combination therapy resulted in tumor regression in 60% of the mice.Treating mouse models of astrocytomas with a new combination therapy resulted in tumor regression in 60% of the mice.